| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 5e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.24 | 8e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |